No takes yet. Share an insight, caveat, or question.
Systematic review examines glibenclamide's effects on outcomes in post-stroke patients, suggesting no significant benefits and increased hypoglycemia risk.
Damaceno et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: